Automated analyses of HPLC profiles of microbial extracts a new tool for drug discovery screening

Natural Products: Drug Discovery and Therapeutic Medicine

Volumn , Issue , 2005, Pages 57-75

  Tormo, José R ^a   García, Juan B ^a  

^a Medical affairs Merck sharp and Dohme ltd   (Spain)

Author keywords

actinomycetes; automation; chemical diversity; extraction solvent; fermentation format; fermentation media; fungi; HPLC; metabolite profiles; taxonomy

Indexed keywords

EID: 53349104017     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-59259-976-9_3     Document Type: Chapter

References (20)

1. Oprea TI, Davis AM, Teague SJ, Leeson P. Is there a difference between leads and drugs? A historical perspective. J Chem Inf Comput Sci 2001;41:1308-1315.
2. Lipinski CA, Lombardo F, Dominy BW, Freeney PJ. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev 1997;23:3-25.
3. Peláez F, Genilloud O. Microorganisms for Health Care, Food and Enzyme Production. 1. Discovering new drugs from microbial natural products. Research Signpost Ed, Kerala, India. 2003;1-22.
4. Müller-Kuhrt L. Putting nature back into drug discovery. Nature Biotech 2003;21:602.
5. Bindseil KU, Jakupovic J, Wolf D, Lavayre J, Leboul J, van der Pyl D. Pure compound libraries; a new perspective for natural product based drug discovery. Drug Disc Today 2001;6:840-847
6. Yarbrough GG, Taylor DP, Rowlands RT, Crawford MS, Lasure L. Screening microbial metabolites for new drugs: theoretical and practical issues. J Antibiot 1993;46:535-544.
7. Cordell GA, Shin YG. Finding the needle in the haystack. The dereplication of natural product extracts. Pure Appli Chem 1999;71:1089-1094.
8. Monaghan RL, Polishook JD, Pecore VJ, Bills GF, Nallin-Omstead M, Streicher SL. Discovery of novel secondary metabolites from fungi-is it really a random walk through a random forest? Can J Bot 1995;73:S925-S931.
9. García JB, Tormo JR. HPLC Studio: a new software utility to perform HPLC chromatogram comparison for screening purposes. J Biomol Screen 2003;8:305-315.
10. Tormo JR, García JB, De Antonio M, et al. A method for the selection of production media for actinomycete strains based on their metabolite HPLC profiles. J Ind Mic Biotech 2003;30:582-588.
11. Platas G, Collado J, Martínez H, Arrese M, Peláez F, Díez MT. Implementation of conditions of the inoculum stage for Streptrosporangium cultures. Microbiologia SEM 1997;13:193-200.
12. Platas G, Peláez F, Collado J, Martinez H, Diez MT. Nutritional preferences of a group of Streptosporangium soil isolates. J Biosci Bioen 1999;88:269-275.
13. Hewlett Packard, Agilent. 1995. Understanding Your ChemStation, 5th ed. San Diego, CA, USA.
14. Julian RK, Jr, Higgs RE, Gygi JD, Hilton MD. A method for quantitively differentiating crude natural extracts using high-performing liquid chromatography-electrospray mass spectrometry. Anal Chem 1998;70:3249-3254.
15. Schmid I, Sattler I, Grabley S, Thiericke R. Natural products in high throughput screening: automated high-quality sample preparation. J Biomol Screen 1999;4:15-25
16. Stackebrandt E, Rainey FA, Ward-Rainey NL. Proposal for new hierarchic classification system, Actinobacteria classis nov. Int J Syst Bacteriol 1997;47:479-491.
17. Vilella D, Sánchez M, Platas G, et al. Inhibitors of farnesylation of Ras from a microbial natural products screening program. J Ind Mic Biotech 2000;25:315-327
18. Vandamme P, Pot B, Gillis M, de Vos P, Kersters K, Swings J. Polyphasic taxonomy, a consensus approach to Bacterial Systematics. Microbiol Rev 1996;60:407-438.
19. Fiedler HP. Biosynthetic capacities of actinomycetes. 1. Screening for secondary metabolites by HPLC and UV-visible absorbance spectral libraries. Nat Prod Lett 1993;2:119-128.
20. Sneath PH, Sokal RR. Taxonomic structure. In: Numerical Taxonomy (Kennedy D and Park RB, ed), WH Freeman & Co., San Francisco, USA, 1973, pp. 230-234.